NDC 73377-086 - Linezolid
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 73377-086
- Package NDCs from labels
- 73377-086-01, 73377-086-02
- Manufacturer
- AX Pharmaceutical Corp
- Effective date
- 2024-10-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Linezolid - AX Pharmaceutical Corp | AX Pharmaceutical Corp | 2024-10-22 | BULK INGREDIENT - ANIMAL DRUG |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 73377-086-01 | Linezolid | 1 kg in 1 JAR | POWDER | 1 | 4 | |
| 73377-086-02 | Linezolid | 0.5 kg in 1 JAR | POWDER | 0.5 | 4 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Linezolid | LINEZOLID | Bryant Ranch Prepack | 8a04bdc9-d6f0-4e35-b683-a472a2e4ff04 | 2025-08-26 | Warnings, Adverse reactions | ISQ9I6J12J |
| Linezolid | LINEZOLID | Bryant Ranch Prepack | ab1b4ab5-7338-4b01-963b-43eeb4c9cf1c | 2025-08-26 | Warnings, Adverse reactions | ISQ9I6J12J |
| Linezolid | LINEZOLID | Ascend Laboratories, LLC | 7402aa01-50de-46c8-a341-d30da5b32b1c | 2025-06-13 | Warnings, Adverse reactions | ISQ9I6J12J |
| Linezolid | LINEZOLID | Hikma Pharmaceuticals USA Inc. | fedbffa7-087d-4448-85c9-0350a3947080 | 2025-05-09 | Warnings, Adverse reactions | ISQ9I6J12J |
| Linezolid | LINEZOLID | Camber Pharmaceuticals, Inc. | b239458e-9a3e-49ac-9ac7-a4badc53dff6 | 2025-01-09 | Warnings, Adverse reactions | ISQ9I6J12J |
| Linezolid | LINEZOLID | American Health Packaging | bc12bd87-5ef0-4ebe-bc00-cbd7896ce08c | 2024-11-22 | Warnings, Adverse reactions | ISQ9I6J12J |
| Linezolid | LINEZOLID | Lupin Pharmaceuticals,Inc. | b3c55eb4-50f2-47f0-a424-5a6779518e1d | 2024-09-05 | Warnings, Adverse reactions | ISQ9I6J12J |
| Linezolid | LINEZOLID | Hp Halden Pharma AS | 217f3ee2-2534-4c32-8e9d-09b6d65df4af | 2024-07-17 | Warnings, Adverse reactions | ISQ9I6J12J |
| Zyvox | LINEZOLID | Hp Halden Pharma AS | b0c75e79-bf29-4f1d-a45d-ae28398a52d9 | 2024-05-28 | Warnings, Adverse reactions | ISQ9I6J12J |
| Zyvox | LINEZOLID | Hp Halden Pharma AS | ce57225b-4580-442b-8c48-8045297cbb50 | 2024-05-28 | Warnings, Adverse reactions | ISQ9I6J12J |
| Zyvox | LINEZOLID | Hp Halden Pharma AS | efe6818c-b798-4d1d-8196-6447a305ad71 | 2024-05-28 | Warnings, Adverse reactions | ISQ9I6J12J |
| Linezolid | LINEZOLID | Fresenius Kabi USA, LLC | cc3e3ea4-50aa-49ee-a8bc-fb48bfc8e014 | 2024-04-30 | Warnings, Adverse reactions | ISQ9I6J12J |
| Linezolid | LINEZOLID | Camber Pharmaceuticals, Inc. | a89a37ec-a736-464b-a83a-84bef6ccd702 | 2023-09-15 | Warnings, Adverse reactions | ISQ9I6J12J |
| Linezolid | LINEZOLID | American Health Packaging | e9ac1ad7-7a23-463d-a467-f0ecc7e523e7 | 2023-08-18 | Warnings, Adverse reactions | ISQ9I6J12J |
| Linezolid | LINEZOLID | Alembic Pharmaceuticals Limited | 74f035ec-a0b1-4371-a17b-20b0b11864c9 | 2023-01-30 | Warnings, Adverse reactions | ISQ9I6J12J |
| Linezolid | LINEZOLID | Alembic Pharmaceuticals Inc. | ca930576-62ab-4af5-ac3e-27ca376baca6 | 2020-08-26 | Warnings, Adverse reactions | ISQ9I6J12J |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.